Molecular characteristics and responses to EGFR tyrosine kinase inhibitors in non-small cell lung cancer patients with EGFR exon 19 insertions.

While this finding did not reach statistical significance, possibly due to the small sample size, it suggests a nuanced heterogeneity within 19ins mutations that warrants further exploration with larger cohorts.

also in 111,027 other papers